题名 | Effects of myricetin and quercetin on ticagrelor metabolism and the underlying mechanism |
作者 | |
发表日期 | 2024-04-01 |
发表期刊 | Chemico-biological interactions 影响因子和分区 |
语种 | 英语 |
原始文献类型 | Journal Article |
关键词 | Interaction Myricetin Pharmacokinetic Quercetin Ticagrelor |
其他关键词 | MYOCARDIAL-INFARCTION ; PHARMACOKINETICS ; PREVENTION ; PHARMACODYNAMICS ; INHIBITORS |
摘要 | The aim of this study was to investigate the potential drug-drug interactions (DDIs) between ticagrelor and other drugs as well as their underlying mechanisms. Rat liver microsome (RLM) reaction system was used to screen potential DDIs in vitro, and ultra performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) was applied to detect the levels of ticagrelor and AR-C124910XX, the main metabolite of ticagrelor. A total of 68 drugs were screened, 11 of which inhibited the production of AR-C124910XX to 20% or less, especially two flavonoids (myricetin and quercetin). The half-maximal inhibitory concentration (IC50) of myricetin on ticagrelor was 11.51 ± 0.28 μM in RLM and 17.96 ± 0.54 μM in human liver microsome (HLM). The IC50 of quercetin in inhibiting ticagrelor in RLM and HLM was 16.92 ± 0.49 μM and 60.15 ± 0.43 μM, respectively. They all inhibited the metabolism of ticagrelor through a mixed mechanism. In addition, Sprague-Dawley (SD) rats were used to study the interactions of ticagrelor with selected drugs in vivo. We found that the main pharmacokinetic parameters including AUC (0-t), AUC (0-∞) and Cmax of ticagrelor were significantly increased when ticagrelor was combined with these two flavonoids. Our results suggested that myricetin and quercetin of flavonoids both had significant effects on the metabolism of ticagrelor, providing reference data for the clinical individualized medication of ticagrelor |
出版者 | ELSEVIER IRELAND LTD |
ISSN | 0009-2797 |
EISSN | 1872-7786 |
卷号 | 392 |
DOI | 10.1016/j.cbi.2024.110924 |
页数 | 7 |
WOS类目 | Biochemistry & Molecular Biology ; Pharmacology & Pharmacy ; Toxicology |
WOS研究方向 | Biochemistry & Molecular Biology ; Pharmacology & Pharmacy ; Toxicology |
WOS记录号 | WOS:001194029400001 |
收录类别 | PUBMED ; SCOPUS ; SCIE |
在线发表日期 | 2024-02 |
URL | 查看原文 |
PubMed ID | 38401715 |
SCOPUSEID | 2-s2.0-85186742215 |
通讯作者地址 | [Xu, Ren-ai]The First Affiliated Hospital of Wenzhou Medical University,Zhejiang,Wenzhou,China ; [Lin, Jingjing]The First Affiliated Hospital of Wenzhou Medical University,Zhejiang,Wenzhou,China |
Scopus学科分类 | Toxicology |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | https://kms.wmu.edu.cn/handle/3ETUA0LF/207731 |
专题 | 药学院(分析测试中心) 附属第一医院 药学院(分析测试中心)_分子药理研究与教学中心 |
通讯作者 | Lin, Jingjing; Xu, Ren-ai |
作者单位 | 1.The First Affiliated Hospital of Wenzhou Medical University,Zhejiang,Wenzhou,China; 2.Institute of Molecular Toxicology and Pharmacology,School of Pharmaceutical Sciences,Wenzhou Medical University,Zhejiang,Wenzhou,China |
第一作者单位 | 附属第一医院; 第一临床医学院(信息与工程学院)、附属第一医院; 药学院(分析测试中心) |
通讯作者单位 | 附属第一医院; 第一临床医学院(信息与工程学院)、附属第一医院 |
第一作者的第一单位 | 附属第一医院 |
推荐引用方式 GB/T 7714 | Wang, Jing,Hu, Yingying,Li, Qingqing,et al. Effects of myricetin and quercetin on ticagrelor metabolism and the underlying mechanism[J]. Chemico-biological interactions,2024,392. |
APA | Wang, Jing, Hu, Yingying, Li, Qingqing, Liu, Ya-nan, Lin, Jingjing, & Xu, Ren-ai. (2024). Effects of myricetin and quercetin on ticagrelor metabolism and the underlying mechanism. Chemico-biological interactions, 392. |
MLA | Wang, Jing,et al."Effects of myricetin and quercetin on ticagrelor metabolism and the underlying mechanism".Chemico-biological interactions 392(2024). |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论